Damora Therapeutics, Inc.
DMRA
$20.96
$0.050.24%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/7/2026
-
Tickeron - Stocks
6/6/2026
-
The Cerbat Gem
6/4/2026
-
Tickeron - Stocks
6/3/2026
-
Tickeron - Stocks
6/3/2026
-
Tickeron - Stocks
6/1/2026
-
Globe Newswire
5/30/2026
-
Yahoo! Finance: News
5/30/2026
-
Nasdaq News: Markets
5/30/2026
-
Fool.com Headlines
5/29/2026
-
Tickeron - Stocks
5/27/2026
-
Seeking Alpha - Long Ideas
5/27/2026
-
SeekingAlpha
5/27/2026
-
Tickeron - Stocks
5/26/2026
-
Simply Wall St
5/23/2026
-
Simply Wall St
5/23/2026
-
Tickeron - Stocks
5/23/2026
-
Tickeron - Stocks
5/22/2026
-
Tickeron - Stocks
5/18/2026
-
Simply Wall St
5/17/2026
-
TipRanks Financial Blog
5/15/2026
-
TipRanks Financial Blog
5/15/2026
-
Tickeron - Stocks
5/14/2026
-
Tickeron - Stocks
5/14/2026
-
Tickeron - Stocks
5/14/2026
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 12, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 281 9020
Address
Building 23
Suite 105 - 221 Crescent Street
Waltham, MA 02453
Suite 105 - 221 Crescent Street
Waltham, MA 02453
Country
Year Founded
Business Description
Sector
Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company’s lead product includes DMR-001, a...
more